Controller medications, also known as daily maintenance medications, are a critical tool for managing asthma — reducing daily ...

Although bronchial hyperresponsiveness to cholinergic agents is a main feature of asthma, the role of anticholinergic drugs in chronic asthma management has been largely underestimated.

A common inhaler drug used to treat tens of thousands of British asthma sufferers has been linked to a rare and potentially fatal hormone condition in children. New research, funded by the ...

A NEW clinical trial has found that the asthma drug montelukast does not shorten the duration of symptoms for ...

Asthma is associated with memory problems in children, a new study has found. Further, the early onset of asthma might worsen ...

Upstream Bio garners analyst optimism for its lead drug verekitug, which could disrupt the $7.5 billion asthma biologics ...

“Childhood is a period of rapid improvement in memory and, more generally, cognition. In children with asthma that ...

Researchers identified a protein involved in the generation of pathologic mucus present in plugs, which is a prominent feature of the disease in patients with type 2 inflammatory asthma. The knowledge ...

Opens in a new tab or window Among patients with mild to moderate COVID-19, the asthma drug montelukast (Singulair) did not reduce duration of symptoms, results of the randomized controlled ACTIV ...

New Delhi: The drug major Sanofi Healthcare has got approval from the Subject Expert Committee (SEC) functional under the ...